+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Emergent BioSolutions, Inc. - logo

Emergent BioSolutions manufactures immunobiotics such as vaccines and immune globulins that assist the body’s immune system. The company’s biodefense segment develops drugs such as BioThrax, a vaccine for the prevention of anthrax, for use against biological agents. Other products in preclinical development include drugs for the treatment of patients exposed to anthrax and botulinum toxin. The company, which was founded in 1998, is based in Rockville, Maryland.

Antibiotic Collaboration and Licensing Deals 2016-2024 - Product Thumbnail Image

Antibiotic Collaboration and Licensing Deals 2016-2024

  • Report
  • May 2024
  • 100 Pages
  • Global
From
From
From
From
From
From
Influenza Vaccine Market - Forecasts from 2019 to 2024 - Product Thumbnail Image

Influenza Vaccine Market - Forecasts from 2019 to 2024

  • Report
  • January 2019
  • 105 Pages
  • Global
From
Opium (Opioid) Addiction - Pipeline Review, H2 2020 - Product Thumbnail Image

Opium (Opioid) Addiction - Pipeline Review, H2 2020

  • Drug Pipelines
  • September 2020
  • 193 Pages
  • Global
From
Leukemia Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Leukemia Therapeutics - Global Strategic Business Report

  • Report
  • May 2024
  • 193 Pages
  • Global
From
From
Market Spotlight: Zika virus - Product Thumbnail Image

Market Spotlight: Zika virus

  • Report
  • February 2021
  • 24 Pages
  • Global
Loading Indicator